These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. Weiss CD, White JM. J Virol; 1993 Dec; 67(12):7060-6. PubMed ID: 8230430 [Abstract] [Full Text] [Related]
23. Sulfation of the human immunodeficiency virus envelope glycoprotein. Bernstein HB, Compans RW. J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500 [Abstract] [Full Text] [Related]
24. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells. Wells DE, Compans RW. Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957 [Abstract] [Full Text] [Related]
25. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Li Y, Luo L, Thomas DY, Kang CY. Virology; 2000 Jul 05; 272(2):417-28. PubMed ID: 10873786 [Abstract] [Full Text] [Related]
26. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase. Kamoshita K, Shiota M, Sasaki M, Koga Y, Okumura Y, Kido H. J Biochem; 1995 Jun 05; 117(6):1244-53. PubMed ID: 7490267 [Abstract] [Full Text] [Related]
27. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. Guo HG, Veronese FM, Tschachler E, Pal R, Kalyanaraman VS, Gallo RC, Reitz MS. Virology; 1990 Jan 05; 174(1):217-24. PubMed ID: 2104682 [Abstract] [Full Text] [Related]
28. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. Chirmule N, Goonewardena H, Pahwa S, Pasieka R, Kalyanaraman VS, Pahwa S. J Biol Chem; 1995 Aug 18; 270(33):19364-9. PubMed ID: 7642615 [Abstract] [Full Text] [Related]
29. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). Decroly E, Vandenbranden M, Ruysschaert JM, Cogniaux J, Jacob GS, Howard SC, Marshall G, Kompelli A, Basak A, Jean F. J Biol Chem; 1994 Apr 22; 269(16):12240-7. PubMed ID: 8163529 [Abstract] [Full Text] [Related]
30. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism. Ahmad A, Yao XA, Tanner JE, Cohen E, Menezes J. J Acquir Immune Defic Syndr (1988); 1994 Aug 22; 7(8):789-98. PubMed ID: 7912729 [Abstract] [Full Text] [Related]
31. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. Cefai D, Debre P, Kaczorek M, Idziorek T, Autran B, Bismuth G. J Clin Invest; 1990 Dec 22; 86(6):2117-24. PubMed ID: 1979339 [Abstract] [Full Text] [Related]
32. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. Srinivas SK, Srinivas RV, Anantharamaiah GM, Compans RW, Segrest JP. J Biol Chem; 1993 Oct 25; 268(30):22895-9. PubMed ID: 8226798 [Abstract] [Full Text] [Related]
33. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. Benjouad A, Gluckman JC, Rochat H, Montagnier L, Bahraoui E. J Virol; 1992 Apr 25; 66(4):2473-83. PubMed ID: 1347797 [Abstract] [Full Text] [Related]
34. Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface. Martin RA, Nayak DP. Virology; 1996 Jun 15; 220(2):473-9. PubMed ID: 8661397 [Abstract] [Full Text] [Related]
35. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor. Moulard M, Achstetter T, Kieny MP, Montagnier L, Bahraoui E. Eur J Biochem; 1994 Oct 15; 225(2):565-72. PubMed ID: 7957171 [Abstract] [Full Text] [Related]
36. Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity. Singhal PC, Sagar S, Chandra D, Garg P. Am J Pathol; 1995 Jul 15; 147(1):25-32. PubMed ID: 7604883 [Abstract] [Full Text] [Related]
37. Effects of mutations in constant regions 3 and 4 of envelope of simian immunodeficiency virus. Morrison HG, Kirchhoff F, Desrosiers RC. Virology; 1995 Jul 10; 210(2):448-55. PubMed ID: 7618279 [Abstract] [Full Text] [Related]
38. HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs. Merzouki A, Patel P, Cassol S, Ennaji M, Tailor P, Turcotte FR, O'Shaughnessy M, Arella M. Cell Mol Biol (Noisy-le-grand); 1995 May 10; 41(3):445-52. PubMed ID: 7580840 [Abstract] [Full Text] [Related]
39. Correlation between high level gp160 expression and reduced CD4 biosynthesis in clonal derivatives of human immunodeficiency virus type 1-infected U-937 cells. Geleziunas R, Bour S, Wainberg MA. J Gen Virol; 1994 Apr 10; 75 ( Pt 4)():857-65. PubMed ID: 8151301 [Abstract] [Full Text] [Related]
40. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. Travis BM, Dykers TI, Hewgill D, Ledbetter J, Tsu TT, Hu SL, Lewis JB. Virology; 1992 Jan 10; 186(1):313-7. PubMed ID: 1727607 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]